JP5232979B2 - Cholesterol reducing agent - Google Patents

Cholesterol reducing agent Download PDF

Info

Publication number
JP5232979B2
JP5232979B2 JP2009035709A JP2009035709A JP5232979B2 JP 5232979 B2 JP5232979 B2 JP 5232979B2 JP 2009035709 A JP2009035709 A JP 2009035709A JP 2009035709 A JP2009035709 A JP 2009035709A JP 5232979 B2 JP5232979 B2 JP 5232979B2
Authority
JP
Japan
Prior art keywords
fraction
catechin
tea
tea leaves
leaves
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009035709A
Other languages
Japanese (ja)
Other versions
JP2010189321A (en
Inventor
裕次 宮田
政之 野田
圭 玉屋
誠剛 林田
知則 徳嶋
隆 田中
一成 田中
靜香 田丸
利郎 松井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyushu University NUC
Nagasaki Prefectural and Municipal Universities Corp
Nagasaki Prefectural Government
Original Assignee
Kyushu University NUC
Nagasaki Prefectural and Municipal Universities Corp
Nagasaki Prefectural Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyushu University NUC, Nagasaki Prefectural and Municipal Universities Corp, Nagasaki Prefectural Government filed Critical Kyushu University NUC
Priority to JP2009035709A priority Critical patent/JP5232979B2/en
Publication of JP2010189321A publication Critical patent/JP2010189321A/en
Application granted granted Critical
Publication of JP5232979B2 publication Critical patent/JP5232979B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本発明はコレステロール低減剤に関する。   The present invention relates to a cholesterol reducing agent.

コレステロールは、食品中に含まれ食事によって摂取するものと、体内で合成されるものとがある。コレステロールは細胞膜や性ホルモンの材料になる成分であるが、過剰摂取などによって体内に増え過ぎると、生活習慣病をまねくおそれがある。例えば、血液中のコレステロールが増加すると、動脈硬化が進行し狭心症や心筋梗塞などの虚血性心疾患、脳出血や脳梗塞などの脳卒中の原因になりやすい。   Cholesterol is either contained in food and taken by meal, or is synthesized in the body. Cholesterol is a component that becomes a material for cell membranes and sex hormones, but if it increases too much in the body due to overdose, it may lead to lifestyle-related diseases. For example, when cholesterol in the blood increases, arteriosclerosis progresses and is likely to cause ischemic heart diseases such as angina pectoris and myocardial infarction, and strokes such as cerebral hemorrhage and cerebral infarction.

下記特許文献1には、茶に由来するテアフラビン類を有効成分とするコレステロール低下用組成物が開示されている。なおこの文献には茶に由来するテアルビジン類も高脂血症及び/又は高コレステロール血症の治療において有用であり得ることを信じている、との記載があるが、該テアルビジン類の有効性を示す試験例は無い。   Patent Document 1 below discloses a cholesterol-lowering composition containing tea flavins derived from tea as active ingredients. In addition, although this literature describes that thealvidin derived from tea is believed to be useful in the treatment of hyperlipidemia and / or hypercholesterolemia, the effectiveness of the thealvidin is described. There are no test examples to show.

特開2004−155784号公報JP 2004-155784 A

コレステロール低減剤としては、安全性が高いものが望ましい。
本発明者等は、茶の葉とビワ葉を一緒に揉みこんだ混合発酵茶葉の抽出液にコレステロールを低減させる効果があることを見出し、それに着目して鋭意研究を重ねた結果、コレステロール低減に有効な成分を突き止めたので、これを特許出願するものである。
As a cholesterol reducing agent, a highly safe thing is desirable.
The present inventors have found that an extract of mixed fermented tea leaves mixed with tea leaves and loquat leaves has the effect of reducing cholesterol, and as a result of intensive research focusing on it, as a result of reducing cholesterol, Since an effective component has been found, a patent application is filed.

本発明は、テアシネンシン、および数平均分子量が5,970かつ重量平均分子量が13,200であるカテキン酸化重合体からなる群から選ばれる1種以上を有効成分として含有するコレステロール低減剤を提供する。   The present invention provides a cholesterol-reducing agent containing as an active ingredient at least one selected from the group consisting of theacinensin and a catechin oxidation polymer having a number average molecular weight of 5,970 and a weight average molecular weight of 13,200.

本発明によれば、安全性が高いコレステロール低減剤が得られる。   According to the present invention, a highly safe cholesterol-reducing agent can be obtained.

本発明に係る混合発酵茶葉の成分分画方法を説明するための図である。It is a figure for demonstrating the component fractionation method of the mixed fermented tea leaves which concern on this invention. 本発明に係る製造例で得られたフラクションのHPLCによるクロマトグラムである。It is the chromatogram by HPLC of the fraction obtained by the manufacture example which concerns on this invention. 本発明に係る有効成分の構造式である。It is a structural formula of the active ingredient which concerns on this invention. 本発明に係る有効成分および比較成分の13C−NMRスペクトルである。It is a 13 C-NMR spectrum of an active ingredient and a comparative ingredient concerning the present invention. 本発明に係る有効成分の推定部分構造式である。3 is an estimated partial structural formula of an active ingredient according to the present invention.

本発明において、有効成分として用いられる(1)テアシネンシンおよび(2)数平均分子量が5,970かつ重量平均分子量が13,200であるカテキン酸化重合体は、いずれも、茶の葉とビワ葉を原料として製造された混合発酵茶葉から得られる。
上記(2)カテキン酸化重合体は、後述の[実施例]に示されるように、茶葉に含まれる4種のカテキン(エピガロカテキン、エピカテキン、エピガロカテキンガレート、エピカテキンガレート)が酸化的に結合して生成した高分子化合物で、分子量は数平均分子量(Mn)5,970、重量平均分子量(Mw)13,200と推定される。一般に茶葉だけを発酵させて製造した紅茶にもカテキン酸化重合体が含まれる。
In the present invention, (1) theacinensin used as an active ingredient and (2) a catechin oxidation polymer having a number average molecular weight of 5,970 and a weight average molecular weight of 13,200 are both tea leaves and loquat leaves. Obtained from mixed fermented tea leaves produced as a raw material.
As described in (Example) below, the above (2) catechin oxidation polymer is oxidative of four catechins (epigallocatechin, epicatechin, epigallocatechin gallate, epicatechin gallate) contained in tea leaves. The molecular weight is estimated to be a number average molecular weight (Mn) of 5,970 and a weight average molecular weight (Mw) of 13,200. Generally, black tea produced by fermenting only tea leaves also contains a catechin oxidized polymer.

[混合発酵茶葉の製造方法]
混合発酵茶葉は、以下の方法で製造することができる。
原料として用いられる茶の葉は、いわゆるツバキ科の常緑低木Camellia sinensis L.の葉である。茶の葉としては、一番茶以外に二番茶、三番茶、秋冬番茶、刈番茶なども使用でき、比較的多くのポリフェノール類を含む二番茶以降の安価な茶の葉のほうが好ましい。なお、これらの遅手の番茶は、現在価格が低迷し、かなりのものが廃棄されているが、このものを有効に利用できる。
[Production method of mixed fermented tea leaves]
Mixed fermented tea leaves can be produced by the following method.
The tea leaves used as the raw material are so-called camellia evergreen shrub Camellia sinensis L. Leaves. As the tea leaves, in addition to the first tea, second tea, third tea, autumn / winter tea, banban tea, etc. can be used, and cheap tea leaves after the second tea containing a relatively large amount of polyphenols are preferred. The price of these late banchas is currently sluggish and a considerable amount is discarded, but this can be used effectively.

原料として用いられるビワ葉は、バラ科、植物名「ビワ」の葉であり、特に制限なく用いることができる。   The loquat leaves used as a raw material are leaves of the family Rosaceae and the plant name “Biwa”, and can be used without particular limitation.

混合発酵茶葉を製造するには、まずビワ葉および茶の葉を用意する。前処理として、ビワ葉および茶の葉を必要に応じて乾燥し、含水率を50〜60質量%程度としておくことが好ましい。また適宜の寸法、例えば1〜10mm角程度の大きさに切断しておくことが好ましい。   In order to produce mixed fermented tea leaves, first, loquat leaves and tea leaves are prepared. As pretreatment, it is preferable to dry loquat leaves and tea leaves as necessary, and to keep the water content at about 50 to 60% by mass. Moreover, it is preferable to cut | disconnect to an appropriate dimension, for example, a magnitude | size about 1-10 mm square.

次いで、茶の葉を乾燥し、水分量を減少させ、萎凋させる。この工程では、例えば粗揉機や、直火または電気で加熱した鍋または板状の器具を用い、茶の葉を撹拌しつつ、温度40〜150℃の加熱空気を茶の葉に当てる方法、密閉撹拌容器内に茶の葉を投入し、容器内の空気を吸引して内部を減圧状態として撹拌して乾燥する方法、萎凋槽を用いてネット上に散布した茶の葉の下方から通気する方法などが用いられる。
この萎凋により原料の茶の葉の含水率を45〜65質量%、好ましくは50〜60質量%程度に減少させると、次の揉捻工程で茶の葉から水分が揉み出され難くなるため、有効成分の流亡を防止できる。また後の乾燥工程が短縮できる点でも好ましい。
The tea leaves are then dried, the water content is reduced and wilted. In this process, for example, using a roughing machine, a pot or plate-like appliance heated directly or with electricity, stirring the tea leaves and applying heated air at a temperature of 40 to 150 ° C. to the tea leaves, sealing A method in which tea leaves are put into a stirring container, the air in the container is sucked and the inside is decompressed and stirred and dried, and a method in which air is blown from below the tea leaves sprayed on the net using a wilt tank Etc. are used.
If the moisture content of the raw tea leaves is reduced to 45 to 65% by mass, preferably about 50 to 60% by this wilting, it will be difficult to ooze water from the tea leaves in the next twisting step. Prevents the loss of ingredients. It is also preferable in that the subsequent drying step can be shortened.

次いで、萎凋工程を経た原料の茶の葉を加圧しながら揉む(揉捻する)とともに、この揉捻時にビワ葉を添加して、両者を一緒に揉捻する。ビワ葉は茶の葉の揉捻開始と同時に添加してもよく、あるいは一定時間茶の葉のみの揉捻を行った後、びわ葉を添加してさらに揉捻してもよい。全揉捻時間のうち、揉捻開始から0〜40%の時間が経過したのち、ビワ葉を添加することが好ましい。ビワ葉を揉捻工程の最初から添加しておくことがより好ましい。
この揉捻により、茶の葉およびビワ葉の組織が破壊され、茶の葉に含まれるポリフェノールオキシダーゼなどの酸化酵素が茶の葉およびビワ葉に含まれるポリフェノールを酸化、重合し、酸化重合物が生成する。
Next, the raw tea leaves that have undergone the wilting process are massaged while being pressed (twisted), and loquat leaves are added at the time of this twisting, and both are twisted together. Loquat leaves may be added simultaneously with the start of tea leaf twisting, or after only tea leaf twisting for a certain period of time, loquat leaves may be added and further twisted. It is preferable to add loquat leaves after 0 to 40% of the total twisting time has elapsed since the start of twisting. It is more preferable to add loquat leaves from the beginning of the twisting process.
This twisting destroys the tissue of tea leaves and loquat leaves, and oxidative enzymes such as polyphenol oxidase contained in tea leaves oxidize and polymerize polyphenols contained in tea leaves and loquat leaves, producing an oxidized polymer. To do.

ビワ葉の添加量は、ビワ葉/茶の葉の絶乾質量比が、5/95〜35/65の範囲が好ましく、8/92〜25/75の範囲がより好ましい。ビワ葉の添加量が上記範囲内であれば、上記(1)、(2)の有効成分が効率良く得られ、特に上記(2)カテキン酸化重合体が効率良く生成する。
揉捻は、茶の葉の揉捻に用いられている通常の揉捻機を用いる方法など、公知の方法を適宜採用できる。揉捻時間は15〜25分が好ましい。揉捻時の原料の温度は20〜40℃が好ましい。20℃未満では発酵不足となり、40℃を越えると上記(1)、(2)の有効成分が効率良く得られない。
The amount of loquat leaves added is preferably in the range of 5/95 to 35/65, more preferably 8/92 to 25/75. When the amount of loquat leaf added is within the above range, the active ingredients (1) and (2) can be obtained efficiently, and particularly the (2) catechin oxidized polymer is efficiently produced.
For the twisting, a known method such as a method using a normal twisting machine used for twisting tea leaves can be appropriately employed. The twisting time is preferably 15 to 25 minutes. The temperature of the raw material during twisting is preferably 20 to 40 ° C. If it is less than 20 ° C., fermentation is insufficient, and if it exceeds 40 ° C., the active ingredients (1) and (2) cannot be obtained efficiently.

次いで発酵工程を行う。すなわち、揉捻後の混合原料を数cmの厚さに堆積させた状態で、温度20〜27℃、湿度30〜60%RHの発酵室内などの環境下に静置する。なお、茶類の製造工程における「発酵」とは葉中の酸化酵素による酸化反応を意味する。
発酵時間は0〜4時間が好ましい。揉捻工程の時間は発酵工程に含めない。先の揉捻工程において、揉捻の開始と同時に発酵が開始するため、揉捻工程とは別に発酵工程を設けなくても、すなわち発酵時間が0時間でも、発酵した混合発酵茶葉を得ることができる。
Next, the fermentation process is performed. That is, in a state where the mixed raw material after twisting is deposited to a thickness of several centimeters, the mixture is left in an environment such as a fermentation chamber at a temperature of 20 to 27 ° C. and a humidity of 30 to 60% RH. “Fermentation” in the tea production process means an oxidation reaction by oxidase in leaves.
The fermentation time is preferably 0 to 4 hours. The time for the twisting process is not included in the fermentation process. In the previous twisting process, fermentation starts simultaneously with the start of the twisting process, so that a fermented mixed fermented tea leaf can be obtained even if a fermentation process is not provided separately from the twisting process, that is, even if the fermentation time is 0 hours.

次いで、所定の発酵時間が経過したならば、原料を加熱して発酵を止め、乾燥する。例えば、連続式乾燥機に原料を投入し、これに温度80〜120℃の熱風を吹き込み、排気温度が50〜60℃となるように操作する。加熱時間は10〜30分程度で十分であり、これにより原料中の含水率を5質量%程度とする。   Next, when a predetermined fermentation time has elapsed, the raw material is heated to stop the fermentation and dried. For example, raw materials are put into a continuous dryer, hot air having a temperature of 80 to 120 ° C. is blown into the continuous dryer, and the exhaust temperature is controlled to be 50 to 60 ° C. A heating time of about 10 to 30 minutes is sufficient, so that the water content in the raw material is about 5% by mass.

こうして混合発酵茶葉が得られる。本発明で用いられる混合発酵茶葉は、加熱工程後の荒茶でもよく、これに必要に応じて仕上げ加工を施した仕上げ茶でもよく、荒茶または仕上げ茶を適宜の大きさに粉砕して粉末状としたものでもよい。   In this way, mixed fermented tea leaves are obtained. The mixed fermented tea leaves used in the present invention may be crude tea after the heating process, or may be finished tea that has been subjected to finishing processing as necessary, and the crude tea or finished tea is pulverized to an appropriate size and powdered. It may be a shape.

[有効成分の分画]
混合発酵茶葉を抽出し、該抽出液から有効成分(1)、(2)を分画する。抽出溶媒は水または有機溶媒が用いられる。有機溶媒と水の混合物を抽出溶媒として用いてもよい。有機溶媒の具定例としてはメタノール、エタノール、アセトン等が挙げられる。
抽出方法および抽出液から有効成分を分画する方法は特に制限されないが、図1に示す方法で行うと有効成分(1)、(2)を効率良く得ることができる。
また、本発明における混合発酵茶葉の抽出液にはテアフラビンも含まれており、有効成分(1)、(2)を分画すると同時にテアフラビンを分画することができる。上記特許文献1に開示されているように、テアフラビンもコレステロール低減に有効な成分である。
[Fractionation of active ingredients]
Mixed fermented tea leaves are extracted, and active ingredients (1) and (2) are fractionated from the extract. As the extraction solvent, water or an organic solvent is used. A mixture of an organic solvent and water may be used as the extraction solvent. Specific examples of the organic solvent include methanol, ethanol, acetone and the like.
The extraction method and the method for fractionating the active ingredient from the extract are not particularly limited, but the active ingredients (1) and (2) can be efficiently obtained by the method shown in FIG.
The extract of mixed fermented tea leaves in the present invention also contains theaflavin, and theaflavins can be fractionated simultaneously with the fractionation of the active ingredients (1) and (2). As disclosed in Patent Document 1, theaflavin is also an effective component for reducing cholesterol.

まず、抽出溶媒として水を用いて混合発酵茶葉の抽出を行い、固液分離を行って抽出液1と残滓2を得る。水の温度は10〜25℃程度が好ましい。この工程では主に糖・カフェイン糖が抽出される。有効成分(1)、(2)、およびテアフラビンを含むポリフェノール類の一部も抽出される。得られた抽出液1を、セファデックスLH−20カラムを用いた吸着クロマトグラフイーに供し、糖およびカフェイン類を透過させ、ポリフェノール類だけを吸着させる。
一方、上記残滓2を有機溶媒で抽出して抽出液3を得る。この工程で、水抽出後の茶葉(残滓2)に含まれるポリフェノール類が抽出される。抽出液3を得る際は、抽出操作後に有機溶媒を除去して濃縮し、さらに不要な固形分(残渣4)を取り除いて抽出液3とすることが好ましい。こうして得られた抽出液3を、前記抽出液1の処理を終えたセファデックスLH−20カラムに通し、低いアルコール濃度の溶媒を用いて残存する糖、カフェイン、フラボノール配糖体を洗い流し、アルコール濃度を上げて有効成分を溶出させ、上記(1)テアシネンシン、(2)カテキン酸化重合体、およびテアフラビンを含むフラクション2を得る。
First, mixed fermented tea leaves are extracted using water as an extraction solvent, and solid-liquid separation is performed to obtain an extract 1 and a residue 2. The temperature of water is preferably about 10 to 25 ° C. In this process, sugar and caffeine sugar are mainly extracted. A part of polyphenols containing active ingredients (1), (2) and theaflavin is also extracted. The obtained extract 1 is subjected to adsorption chromatography using a Sephadex LH-20 column to allow sugar and caffeine to permeate and adsorb only polyphenols.
On the other hand, the residue 2 is extracted with an organic solvent to obtain an extract 3. In this step, polyphenols contained in the tea leaves (residue 2) after water extraction are extracted. When obtaining the extract 3, it is preferable to remove the organic solvent after the extraction operation and concentrate, and further remove unnecessary solids (residue 4) to obtain the extract 3. The extract 3 thus obtained is passed through a Sephadex LH-20 column that has been treated with the extract 1, and the remaining sugar, caffeine, and flavonol glycoside are washed away using a solvent having a low alcohol concentration, The active ingredient is eluted by increasing the concentration to obtain Fraction 2 containing (1) theacinensin, (2) catechin oxidized polymer, and theaflavin.

次に、得られたフラクション2を、7M尿素−アセトン混合液を溶媒とするセファデックスLH−20カラムを用いたゲルパーミエーションクロマトグラフィーにより、分子量が大きいカテキン酸化重合体を含むフラクション2−1と、分子量が比較的小さいテアシネンシンとテアフアラビンを含むフラクション2−2に分画する。
フラクション2−1からアセトンを留去して水溶液として、ダイアイオンHP20SSカラムを用いたゲルパーミエーションクロマトグラフィーに供し、尿素と塩酸を水で洗い流し、アルコールでポリフェノールを溶出することにより、目的とする(2)カテキン酸化重合体のフラクション3−1が得られる。
一方、フラクション2−2もアセトンを留去した後、ダイアイオンHP20SSカラムを用いた吸着クロマトグラフィーに供し、尿素と塩酸を水で洗い流した後、アルコール濃度を増加させながらアルコールで溶出することにより、テアシネンシン類とテアフラビン類が分離され、目的とする(1)テアシネンシンのフラクション3−2、およびテアフラビンのフラクション3−3が得られる。
Next, the obtained fraction 2 was subjected to gel permeation chromatography using a Sephadex LH-20 column using a 7M urea-acetone mixed solution as a solvent, and fraction 2-1 containing a catechin oxide polymer having a large molecular weight was obtained. Fraction 2-2, which contains theacinensin and theaarabin with relatively low molecular weight.
Acetone is distilled off from the fraction 2-1, which is used as an aqueous solution for gel permeation chromatography using a Diaion HP20SS column. The urea and hydrochloric acid are washed away with water, and the polyphenol is eluted with alcohol. 2) A fraction 3-1 of the catechin oxidized polymer is obtained.
On the other hand, fraction 2-2 was also subjected to adsorption chromatography using a Diaion HP20SS column after distilling off acetone, and after rinsing urea and hydrochloric acid with water, elution with alcohol while increasing the alcohol concentration, Theacinensins and theaflavins are separated, and the desired (1) fraction 3-2 of theacinensin and fraction 3-3 of theaflavin are obtained.

図1に示す抽出および分画方法にあっては、まず混合発酵茶葉を水で抽出して、水溶性成分を多く含み、ポフェノール類の含有量が少ない抽出液1を得るため、該抽出液を濃縮せずにカラムに通して糖およびカフェイン類を容易に分離・除去することができる。仮に、カラムに通す抽出液に糖分が高濃度で含まれていると、ゲルの収縮が生じ易くカラムへの負荷が大きくなるが、上記の方法では、かかる不都合を防止できる。また抽出液を濃縮する手間も省ける。
また、フラクション2の分画に、7M尿素−アセトン混液を溶媒とするセファデックスLH−20を用いたゲルパーミエーションクロマトグラフィーを適用することにより、1段階で分子量が大きい(2)カテキン酸化重合体を含むフラクション2−1と、分子量が比較的小さい(1)テアシネンシンとテアフアラビンを含む画分であるフラクション2−2に分けることができる。
さらに、フラクション2−2から尿素を除く段階でダイアイオンHP20SSカラムクロマトを用いることにより、(1)テアシネンシン類とテアフラビン類が分離されて溶出され、極めて効率的に目的の有効成分を得ることができる。
In the extraction and fractionation method shown in FIG. 1, first, mixed fermented tea leaves are extracted with water to obtain an extract 1 containing a large amount of water-soluble components and a low content of pophenols. The sugar and caffeine can be easily separated and removed by passing through a column without concentrating. If the extract contained in the column contains a high concentration of sugar, the gel tends to shrink and the load on the column increases. However, the above method can prevent such inconvenience. Moreover, the trouble of concentrating the extract can be saved.
Further, by applying gel permeation chromatography using Sephadex LH-20 with 7M urea-acetone mixture as a solvent to fraction 2 fraction, (2) catechin oxidized polymer having a large molecular weight in one step And a fraction 2-1 that is a fraction containing a relatively small molecular weight (1) theacinensin and theaarabin.
Furthermore, by using Diaion HP20SS column chromatography at the stage of removing urea from fraction 2-2, (1) theasinensins and theaflavins are separated and eluted, and the target active ingredient can be obtained very efficiently. .

[コレステロール低減剤]
このようにして得られる上記(1)テアシネンシン、及び(2)カテキン酸化重合体をそれぞれ含むフラクションは、そのまま本発明のコレステロール低減剤(以下、本発明の剤ということがある。)として用いることができる。該フラクションに対して、溶媒除去、濃縮、乾燥等の後処理を適宜施したものを本発明の剤の有効成分として用いてもよい。
本発明の剤は、上記(1)テアシネンシン、及び(2)カテキン酸化重合体からなる群から選ばれる1種以上を有効成分として含有する。これらはいずれか一種でもよく、2種以上を併用してもよい。
本発明の剤は、上記有効成分(1)、(2)の他に、賦形剤、結合剤、崩壊剤、滑沢剤、防腐剤、安定剤、保存剤、矯味矯臭剤、希釈剤、香味剤等の、製剤上許容される1種または2種類以上の添加剤を含有してもよい。
さらに、例えばテアフラビンなど、コレステロール低減作用を有し、安全性が確認されている公知の成分を含有させてもよい。
[Cholesterol reducing agent]
The fractions each containing (1) theacinensin and (2) catechin oxidized polymer thus obtained can be used as they are as the cholesterol reducing agent of the present invention (hereinafter sometimes referred to as the agent of the present invention). it can. Those obtained by appropriately performing post-treatment such as solvent removal, concentration, and drying on the fraction may be used as an active ingredient of the agent of the present invention.
The agent of the present invention contains one or more selected from the group consisting of (1) theacinensin and (2) a catechin oxidized polymer as an active ingredient. Any of these may be used alone, or two or more of these may be used in combination.
In addition to the active ingredients (1) and (2), the agent of the present invention includes excipients, binders, disintegrants, lubricants, preservatives, stabilizers, preservatives, flavoring agents, diluents, You may contain 1 type, or 2 or more types of additives accept | permitted on formulation, such as a flavoring agent.
Furthermore, you may contain the well-known component which has a cholesterol reduction effect | action and confirmed safety | security, such as theaflavin.

本発明の剤は、これを経口投与することにより、血液中のコレステロール濃度を低減させる効果、および肝臓中のコレステロール濃度を低減させる効果が得られる。投与方法は特に制限されるものではないが、2週間以上の期間にわたって継続的に投与することが好ましい。
本発明の剤の有効投与量は、成人1日当たりの投与量が、(1)テアフラビンおよび(2)カテキン酸化重合体の総量として、10〜5000mgが好ましく、50〜2000mgがより好ましく、50〜700mgがさらに好ましい。
また、上記有効成分(1)、(2)の他に、例えばテアフラビンなどのコレステロール低減作用を有する公知成分を同時に投与する場合は、これらの総量が上記範囲になることが好ましい。
本発明の剤の剤形は、特に制限されないが錠剤、顆粒剤、カプセル剤、水薬、ドリンク剤等の内服剤形とすることが好ましい。このような製剤化は、医薬の製造に用いられる常法に従って行うことができる。
The agent of the present invention can be administered orally to obtain an effect of reducing cholesterol concentration in blood and an effect of reducing cholesterol concentration in liver. The administration method is not particularly limited, but it is preferable to administer continuously over a period of 2 weeks or more.
As for the effective dose of the agent of the present invention, the daily dose for an adult is preferably 10 to 5000 mg, more preferably 50 to 2000 mg, more preferably 50 to 700 mg as the total amount of (1) theaflavin and (2) catechin oxidized polymer. Is more preferable.
In addition to the above active ingredients (1) and (2), when a known ingredient having a cholesterol reducing action such as theaflavin is administered simultaneously, the total amount of these ingredients is preferably within the above range.
The dosage form of the agent of the present invention is not particularly limited, but is preferably an internal dosage form such as a tablet, granule, capsule, liquid medicine, drink or the like. Such formulation can be carried out according to a conventional method used for the production of a medicine.

以下において「%」は特に断りのない限り「質量%」である。
以下において原料として用いた「茶の葉」はいずれも長崎県総合農林試験場東彼杵茶葉支場で栽培したヤブキタ種の三番茶の葉である。
[参考例1:混合発酵茶葉の製造]
茶の葉にビワ葉を投入し、揉捻機で揉み込んだ。茶の葉とビワ葉の配合割合は茶の葉:ビワ茶の絶乾質量比が9:2とした。揉み込みの時間は20分とし、揉捻時の原料の温度は33℃とした。この後、直ちに熱風式乾燥機内に移し、100℃で30分間加熱することにより、発酵を止めるとともに乾燥した。こうして含水率5質量%の混合発酵茶葉を得た。
In the following, “%” is “% by mass” unless otherwise specified.
The "tea leaves" used as raw materials in the following are all the third tea leaves of Yabukita cultivated at the Nagasaki Prefectural Agricultural and Forestry Experiment Station Higashisonobe Tea Leaf Branch.
[Reference Example 1: Production of mixed fermented tea leaves]
The loquat leaves were put into the tea leaves and swallowed with a twister. The blending ratio of tea leaves and loquat leaves was a tea leaf: lowa dry tea mass ratio of 9: 2. The squeezing time was 20 minutes, and the temperature of the raw material during twisting was 33 ° C. After this, it was immediately transferred into a hot air drier and heated at 100 ° C. for 30 minutes to stop fermentation and dry. Thus, a mixed fermented tea leaf having a water content of 5% by mass was obtained.

<製造例1>
(抽出および分画)
図1に示す手順で、有効成分の抽出および分画を行った。
まず、参考例1で得た混合発酵茶葉1930gを水(15℃)30Lに浸し、室温で2日間抽出した後、吸引ろ過した。得られたろ液(抽出液1)を、水で置換したセファデックスLH−20カラム(ファルマシア・ファイン・ケミカル社製、ゲル直径10cm、長さ35cm)にそのまま流し込み、ポリフェノールを吸着させた。
一方、残滓2として得られる、水抽出後の茶葉は、50%アセトン水溶液(アセトン:水の容量比=1:1)30Lで、2日間、室温での抽出を2回繰り返し、2回分のろ液を合わせてロータリーエバポレーターでアセトンを留去した。得られた沈殿を含む溶液に20容量%の濃度となるようにメタノールを加えて攪拌し、溶けずに残ったクロロフィルなどをろ過して除いた。得られたろ液(抽出液3)を、上記抽出液1を通導したセファデックスLH−20カラムに続けて流し込んだ。
次いでカラムに40%メタノール(メタノール:水の容量比=4:6、以下同様。)の2Lを流し、糖類、カフェイン及びフラボノール配糖体を流出させた。さらにカラムに60%メタノールの2L、80%メタノールの2L、100%メタノールの4L、メタノール−アセトン−水混合液(メタノール:アセトン:水の容量比=8:1:1)の2L、およびアセトン水混合液(アセトン:水の容量比=6:2)の6Lを、この順に流して成分を溶出させた。溶出液は250mlずつガラス容器に分け取り、それぞれについて蛍光剤入りシリカゲル薄層クロマトグラフィー(展開溶媒はトルエン:ギ酸エチル:ギ酸の容量比=1:7:1の混合液、検出は紫外吸収、及び塩化鉄(III)試薬噴霧)で成分を確認することで分画し、ロータリーエバポレーターで濃縮乾固した。
こうして、主にカテキン類を含むフラクション1(52.3g)と、テアシネンシン、テアフラビン、及びカテキン酸化重合体を含むフラクション2(74.6g)を得た。
<Production Example 1>
(Extraction and fractionation)
The active ingredient was extracted and fractionated by the procedure shown in FIG.
First, 1930 g of mixed fermented tea leaves obtained in Reference Example 1 were immersed in 30 L of water (15 ° C.), extracted at room temperature for 2 days, and then suction filtered. The obtained filtrate (Extract 1) was poured into a Sephadex LH-20 column (Pharmacia Fine Chemicals, gel diameter: 10 cm, length: 35 cm) substituted with water to adsorb polyphenol.
On the other hand, the tea leaves after water extraction obtained as residue 2 are 30 L of 50% acetone aqueous solution (acetone: water volume ratio = 1: 1), and the extraction at room temperature is repeated twice for 2 days. The liquids were combined and acetone was distilled off with a rotary evaporator. Methanol was added to the resulting solution containing the precipitate to a concentration of 20% by volume and stirred, and chlorophyll and the like remaining undissolved were removed by filtration. The obtained filtrate (extract 3) was continuously poured into the Sephadex LH-20 column through which the extract 1 was introduced.
Next, 2 L of 40% methanol (methanol: water volume ratio = 4: 6, the same applies hereinafter) was allowed to flow through the column, and sugars, caffeine and flavonol glycosides were allowed to flow out. Further, 2 L of 60% methanol, 2 L of 80% methanol, 4 L of 100% methanol, 2 L of methanol-acetone-water mixture (methanol: acetone: water volume ratio = 8: 1: 1), and acetone water 6 L of the mixture (acetone: water volume ratio = 6: 2) was flowed in this order to elute the components. The eluate was divided into glass containers of 250 ml each, and silica gel thin layer chromatography containing a fluorescent agent for each (developing solvent was a mixture of toluene: ethyl formate: formic acid volume ratio = 1: 7: 1, detection was ultraviolet absorption, and Fractionation was confirmed by confirming the components with iron (III) chloride spray), and the mixture was concentrated to dryness with a rotary evaporator.
Thus, a fraction 1 (52.3 g) mainly containing catechins and a fraction 2 (74.6 g) containing theacinensin, theaflavin, and a catechin oxidized polymer were obtained.

フラクション2は7M尿素−アセトン混合液(尿素:アセトンの容量比=2:3、塩酸でpH2に調整)に溶解し、同じ溶媒で置換したセファデックスLH−20カラム(ゲル直径10cm、長さ35cm)に流し込み、カテキン酸化重合体を含むフラクション2−1とテアシネンシンとテアフラビンを含むフラクション2−2に分画した。
フラクション2−1はアセトンを留去して水溶液とし、ダイアイオンHP20SSカラム(三菱化学社製、ゲル直径5cm長さ30cm)に流し込み、尿素と塩酸を水で洗い流した後、メタノールでポリフェノールを溶出してカテキン酸化重合体のフラクション3−1(21.4g)を得た。
フラクション2−2もアセトンを留去した後、ダイアイオンHP20SSカラム(ゲル直径5cm長さ30cm)に流し込み、尿素と塩酸を水で洗い流した後、10%メタノールの0.5L、20%メタノールの0.5L、30%メタノールの0.5L、40%メタノールの0.5L、60%メタノールの0.5L、80%メタノールの0.5Lで溶出させ、テアシネンシンのフラクション3−2(8.5g)、その他のポリフェノール混合物のフラクション(7.4g、図示せず)、およびテアフラビン類を主成分とするフラクション3−3(30.1g)を得た。
Fraction 2 was dissolved in 7M urea-acetone mixture (volume ratio of urea: acetone = 2: 3, adjusted to pH 2 with hydrochloric acid) and replaced with the same solvent, Sephadex LH-20 column (gel diameter 10 cm, length 35 cm) And fractionated into a fraction 2-1 containing a catechin oxidized polymer and a fraction 2-2 containing theacinensin and theaflavin.
Fraction 2-1 distills acetone to form an aqueous solution, which is poured into a Diaion HP20SS column (Mitsubishi Chemical Co., Ltd., gel diameter: 5 cm, length: 30 cm). Urea and hydrochloric acid are washed away with water, and polyphenol is eluted with methanol Thus, fraction 3-1 (21.4 g) of the catechin oxidized polymer was obtained.
Fraction 2-2, after distilling acetone off, was poured into a Diaion HP20SS column (gel diameter 5 cm, length 30 cm), urea and hydrochloric acid were washed away with water, 0.5 L of 10% methanol, 0 of 20% methanol. Elution with 0.5 L, 0.5 L of 30% methanol, 0.5 L of 40% methanol, 0.5 L of 60% methanol, 0.5 L of 80% methanol, and fraction 3-2 (8.5 g) of theacinensin, The fraction (7.4g, not shown) of the other polyphenol mixture and the fraction 3-3 (30.1g) which has theaflavins as a main component were obtained.

(同定)
得られたフラクションのHPLC(高速液体クロマトグラフィー)によるクロマトグラムを図2に示す。図2の(A)はカテキン酸化重合体のフラクション3−1、(B)はテアシネンシンのフラクション3−2、(C)はテアフラビン類のフラクション3−3についてのクロマトグラムである。
各試料のHPLC分析条件は以下の通りである。
[カテキン酸化重合体及びテアシネンシンの分析]
カラム:Cosmosil 5C18 AR II(ナカライテスク社製、4.6×250mm)、
カラム温度:35℃、
移動相:A;50mMリン酸、B;CHCN、B 4%から30%(39分間)、30%から75%(15分間)、
流速:0.8ml/min。
[テアフラビン類の分析]
カラム:Cosmosil 5C18 PAQ(ナカライテスク社製、4.6×250mm)、
カラム温度:35℃、
移動相:A;50mMリン酸、B;CHCN、B 10%から25%(5分間)、25%から80%(40分間)、
流速:0.8ml/min。
(Identification)
A chromatogram of the obtained fraction by HPLC (high performance liquid chromatography) is shown in FIG. 2A is a chromatogram for the catechin oxidized polymer fraction 3-1, FIG. 2B is the theacinensin fraction 3-2, and FIG. 2C is the theaflavin fraction 3-3.
The HPLC analysis conditions for each sample are as follows.
[Analysis of Catechin Oxidation Polymer and Theacinensin]
Column: Cosmosil 5C 18 AR II (manufactured by Nacalai Tesque, 4.6 × 250 mm),
Column temperature: 35 ° C.
Mobile phase: A; 50 mM phosphoric acid, B; CH 3 CN, B 4% to 30% (39 minutes), 30% to 75% (15 minutes),
Flow rate: 0.8 ml / min.
[Analysis of theaflavins]
Column: Cosmosil 5C 18 PAQ (manufactured by Nacalai Tesque, 4.6 × 250 mm),
Column temperature: 35 ° C.
Mobile phase: A; 50 mM phosphoric acid, B; CH 3 CN, B 10% to 25% (5 minutes), 25% to 80% (40 minutes),
Flow rate: 0.8 ml / min.

テアシネンシンおよびテアフラビン類は標準品とHPLCクロマトグラフを比較することにより同定した。
図2に示されるように、フラクション3−2の主成分はテアシネンシンA、フラクション3−3の主成分はテアフラビン類である。
テアシネンシンAおよびテアフラビン類の構造式を図3に示す。テアフラビン類のうち、TFは構造式中のRとRが水素原子であるもの、TF3GはRがガロイル基(galloyl)でRが水素原子であるもの、TF3’GはRが水素原子でRがガロイル基であるもの、TFdiGはRとRがガロイル基であるものをそれぞれ示す。
Theasinensins and theaflavins were identified by comparing the standards with HPLC chromatographs.
As shown in FIG. 2, the main component of the fraction 3-2 is theasinensin A, and the main component of the fraction 3-3 is theaflavins.
The structural formulas of theacinensin A and theaflavins are shown in FIG. Among the theaflavins, TF is a compound in which R 1 and R 2 in the structural formula are hydrogen atoms, TF3G is a compound in which R 1 is a galloyl group and R 2 is a hydrogen atom, and TF3′G is a compound in which R 1 is R 1. A hydrogen atom in which R 2 is a galloyl group and TFdiG are those in which R 1 and R 2 are galloyl groups.

(分子量の測定)
上記で得られたカテキン酸化重合体をジメチルホルムアミドに溶解し、ゲルろ過用高速液体クロマトグラフィーで分析した。分析条件は以下の通りとした。
カラム:TSK−gel−α 3000カラム、長さ300mm×径7.8mm、(東ソー社製)、
流速:0.5ml/min、
溶媒:10mM塩化リチウムを含むジメチルホルムアミド、
温度:40℃、
検出:254nmにおける紫外吸収。
ピークトップの保持時間から分子量を推定した。分子量標準品としては、ポリスチレン標準品(分子量4,000、25,000、50,000、及び170,000)、トルエン(分子量92)を用いた。その結果、得られたカテキン酸化重合体の分子量は、数平均分子量(Mn)が5,970、重量平均分子量(Mw)が13,200であった。
(Measurement of molecular weight)
The catechin oxidized polymer obtained above was dissolved in dimethylformamide and analyzed by high performance liquid chromatography for gel filtration. The analysis conditions were as follows.
Column: TSK-gel-α 3000 column, length 300 mm × diameter 7.8 mm (manufactured by Tosoh Corporation),
Flow rate: 0.5 ml / min
Solvent: dimethylformamide containing 10 mM lithium chloride,
Temperature: 40 ° C
Detection: UV absorption at 254 nm.
The molecular weight was estimated from the retention time of the peak top. As molecular weight standard products, polystyrene standard products (molecular weights 4,000, 25,000, 50,000, and 170,000) and toluene (molecular weight 92) were used. As a result, the number average molecular weight (Mn) of the obtained catechin oxidized polymer was 5,970, and the weight average molecular weight (Mw) was 13,200.

<比較製造例1>
製造例1において、混合発酵茶葉に代えて市販紅茶を用いた他は、同様の処理を行って得られたフラクション3−1について、同様にして分子量を測定したところ、数平均分子量(Mn)が2,062、重量平均分子量(Mw)が10,413であった。
<Comparative Production Example 1>
In Production Example 1, the molecular weight was measured in the same manner for the fraction 3-1, which was obtained by carrying out the same treatment except that a commercial black tea was used instead of the mixed fermented tea leaf, and the number average molecular weight (Mn) was It was 2,062 and the weight average molecular weight (Mw) was 10,413.

<測定例1>
製造例1で得られたカテキン酸化重合体を、重水を5%含む重アセトンに溶解し、13C−NMRスペクトルを測定した。その結果を図4に示す。
比較のために、紅茶の高分子ポリフェノールおよび新鮮ビワ葉から得られたプロシアニジン(エピカテキンが酸化的に重合したもの)について、同様にして13C−NMRスペクトルを測定した。その結果を図4に示す。
図4の(A)は製造例1で得られたカテキン酸化重合体、(B)は紅茶の高分子ポリフェノール、(C)はビワ葉のプロシアニジンについてのスペクトルである。
この図の結果より、製造例1で得られたカテキン酸化重合体は、紅茶高分子ポリフェノールの特徴的シグナルとビワ葉プロシアニジンの特徴的シグナルの両方を併せ持つことがわかる。このことから、ビワ葉に含まれるプロシアニジンが共存しているか、あるいは茶カテキンと共重合している可能性もある。
また、図4(A)の13C−NMRスペクトルは、カテキン骨格に共通のシグナル(図中Fで示す。)に加えて、エピガロカテキンに特徴的なピロガロール型カテキンのシグナル(図中pyrで示す。)とエピカテキンに特徴的なカテコール型カテキン由来のシグナル(図中catで示す。)、さらにそれらにエステル結合したガロイル基由来のシグナル(図中Gで示す。)を示している。このことより、製造例1で得られたカテキン酸化重合体は、茶葉に含まれる4種のカテキン(エピガロカテキン、エピカテキン、エピガロカテキンガレート、エピカテキンガレート)が酸化的に結合して生成した高分子化合物であることがわかる。
製造例1で得られたカテキン酸化重合体の推定部分構造式を図5に示す。該推定部分構造式は、カテキンを酵素酸化して得られる物質の化学構造(Li,Y.,et.al.,Pytochemistry,2007,68,1081;Kusano,R.,et.al.,Chem.Pharm.Bull.,2007,56,1768)と、ビワ葉プロアントシアニジンの構造をもとに推定した。
<Measurement Example 1>
The catechin oxidation polymer obtained in Production Example 1 was dissolved in heavy acetone containing 5% heavy water, and a 13 C-NMR spectrum was measured. The result is shown in FIG.
For comparison, 13 C-NMR spectra were measured in the same manner for procyanidins (epicatechin polymerized epicatechin) obtained from black tea polymer polyphenols and fresh loquat leaves. The result is shown in FIG.
(A) of FIG. 4 is a spectrum about the catechin oxidation polymer obtained by manufacture example 1, (B) is a high molecular weight polyphenol of black tea, (C) is a spectrum about procyanidins of loquat leaves.
From the result of this figure, it can be seen that the catechin oxidized polymer obtained in Production Example 1 has both the characteristic signal of black tea polymer polyphenol and the characteristic signal of loquat procyanidin. From this, procyanidins contained in loquat leaves may coexist or may be copolymerized with tea catechins.
In addition to the signal common to the catechin skeleton (indicated by F in the figure), the 13 C-NMR spectrum of FIG. 4A shows the signal of pyrogallol-type catechin characteristic of epigallocatechin (indicated by pyr in the figure). And a signal derived from a catechol-type catechin characteristic of epicatechin (indicated by “cat” in the figure), and a signal derived from a galloyl group ester-linked thereto (indicated by “G” in the figure). From this, the catechin oxidation polymer obtained in Production Example 1 is formed by oxidatively binding four kinds of catechins (epigallocatechin, epicatechin, epigallocatechin gallate, epicatechin gallate) contained in tea leaves. It can be seen that this is a polymer compound.
The estimated partial structural formula of the catechin oxidized polymer obtained in Production Example 1 is shown in FIG. The deduced partial structural formula is the chemical structure of a substance obtained by enzymatic oxidation of catechin (Li, Y., et. Al., Pytochemistry, 2007, 68, 1081; Kusano, R., et. Al., Chem. Pharm. Bull., 2007, 56, 1768) and the structure of loquat leaf proanthocyanidins.

<試験例1:血清総コレステロールおよび肝臓総コレステロールに対する効果>
製造例1で得られたテアシネンシン、テアフラビン、およびカテキン酸化重合体を用い、ラットにこれらの成分を含む食餌を摂取させたときの、血清総コレステロール濃度および肝臓総コレステロール濃度に及ぼす影響を調べた。
実験動物として、4週齢のSprague−Dawley(正常ラット)を用い、室温22±1℃、湿度55±5%、8:00〜20:00点灯のライトサイクルの動物飼育室で飼育した。5週齢までは市販のMF固形飼料(オリエンタル酵母(株)製)を与えて予備飼育をし、その後試験食の摂食を開始した。すなわち、5週齢の時に平均体重が同じになるように1群7匹ずつ、(I)群〜(V)群の合計5群に群分けし、以下の試験食を4週間自由摂食させた。
試験食は、AIN−76に基づいた純化食をコントロール食とした。その組成(単位:g/kg)は、カゼイン200、コーン油100、ミネラル混合(AIN−76−MX)35、ビタミン混合(AIN−76−VX)10、セルロース50、重酒石酸コリン2、DL−メチオニン3、コーンスターチ150およびショ糖450である。
(I)群:コントロール食をそのまま試験食として摂取させた。
(II)群:コントロール食に0.2%のテアシネンシンを添加し、その添加分だけショ糖を減じた試験食。
(III)群:コントロール食に0.2%のテアフラビンを添加し、その添加分だけショ糖を減じた試験食。
(IV)群:コントロール食に0.5%のカテキン酸化重合体を添加し、その添加分だけショ糖を減じた試験食。
(V)群:コントロール食に0.2%のテアシネンシンと0.2%のテアフラビンの両方を添加し、その添加分だけショ糖を減じた試験食。
いずれの群も飼育期間中、摂食量と体重は1日おきに測定した。試験食の摂取を開始してから4週間後に血清総コレステロール濃度と肝臓総コレステロール濃度を測定した。測定結果を表1に示す。
<Test Example 1: Effect on serum total cholesterol and liver total cholesterol>
Using the theacinensin, theaflavin, and the catechin oxidized polymer obtained in Production Example 1, the effects on the serum total cholesterol concentration and the liver total cholesterol concentration when rats were fed a diet containing these components were examined.
A 4-week-old Sprague-Dawley (normal rat) was used as an experimental animal, and was raised in an animal breeding room with a light cycle of room temperature 22 ± 1 ° C., humidity 55 ± 5%, and 8:00:00 to 20:00 lighting. Up to 5 weeks of age, a commercially available MF solid feed (produced by Oriental Yeast Co., Ltd.) was given for pre-breeding, and then feeding of the test meal was started. That is, 7 mice per group were grouped into a total of 5 groups (I) to (V) so that the average weight would be the same at the age of 5 weeks, and the following test meals were allowed to eat freely for 4 weeks. It was.
As the test meal, a purified meal based on AIN-76 was used as a control meal. The composition (unit: g / kg) is: casein 200, corn oil 100, mineral mixture (AIN-76-MX) 35, vitamin mixture (AIN-76-VX) 10, cellulose 50, choline bitartrate 2, DL- Methionine 3, corn starch 150 and sucrose 450.
Group (I): A control diet was directly taken as a test diet.
Group (II): A test meal in which 0.2% of theacinensin was added to the control meal and sucrose was reduced by the added amount.
Group (III): A test meal in which 0.2% theaflavin was added to the control meal and sucrose was reduced by the added amount.
Group (IV): A test meal in which 0.5% catechin oxidized polymer was added to the control meal and sucrose was reduced by the added amount.
Group (V): A test meal in which both 0.2% theacinensin and 0.2% theaflavin were added to the control meal, and sucrose was reduced by the added amount.
In both groups, food intake and body weight were measured every other day during the breeding period. Serum total cholesterol concentration and liver total cholesterol concentration were measured 4 weeks after the start of intake of the test meal. The measurement results are shown in Table 1.

血清総コレステロール濃度はcholesterol oxidase・3, 5 - dimethoxy - N - ethyl - N- (2 - hydroxyl - 3 - sulfopropyl) - aniline sodium・DAOS法によるコレステロールE-テストワコー(和光純薬工業社製、大阪)を用いて測定した。
肝臓総コレステロール濃度は、まず肝臓総脂質の抽出をFolch法[Folch J, Lees M, Sloane-stanley GH.:A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem , 226 : 497-506 (1957)]により行い、抽出後、血清総コレステロール濃度と同様の方法で測定した。
Serum total cholesterol concentration is cholesterol esterase 3,5-dimethoxy-N-ethyl-N- (2-hydroxyl-3-sulfopropyl) -aniline sodium-cholesterol E-test Wako by DAOS method (Wako Pure Chemical Industries, Osaka, Japan) ).
The total liver cholesterol concentration was determined by first extracting the total liver lipids using the Folch method [Folch J, Lees M, Sloane-stanley GH .: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem, 226: 497 -506 (1957)], and after extraction, the serum total cholesterol concentration was measured by the same method.

Figure 0005232979
Figure 0005232979

表1の結果より、血清総コレステロール濃度については、0.2%テアシネンシン食を摂食した(II)群、0.2%テアフラビン食を摂食した(III)群、0.5%カテキン酸化重合体食を摂取した(IV)群、0.2%テアシネシン食と0.2%テアフラビン食の両方を含む食餌を摂食した(V)群のラットは、(I)群のラットに比べて大きく低下した。
肝臓総コレステロール濃度については、(I)群に比べて、いずれの群も低下しており、特に0.2%テアシネンシン食を摂食した(II)群および0.5%カテキン酸化重合体食を摂取した(IV)群のラットで大きく低下した。
これらのことから、本発明に係るテアシネンシンおよびカテキン酸化重合体はいずれも、血清総コレステロール濃度および肝臓総コレステロール濃度を低下させる効果を有することが認められた。
またテアフラビンが血清総コレステロール濃度および肝臓総コレステロール濃度を低下させる効果を有することも確認された。
これらの有効成分は、混合発酵茶葉に含まれる成分であるため安全性が高い。
From the results shown in Table 1, the serum total cholesterol concentrations were as follows: (II) group fed with 0.2% theacinensin diet, (III) group fed with 0.2% theaflavin diet, 0.5% catechin oxidation weight The rats in the (IV) group that received the combined diet and the rats in the (V) group that received a diet containing both the 0.2% theacinecin diet and the 0.2% theaflavin diet were larger than the rats in the (I) group. Declined.
The total liver cholesterol levels were lower in all groups compared to group (I), especially in group (II) and 0.2% catechin oxidized polymer diet in which 0.2% theasinensin diet was consumed. The level was significantly reduced in the rats in the (IV) group ingested.
From these facts, it was confirmed that the theasinensin and catechin oxidized polymer according to the present invention have the effect of lowering the serum total cholesterol concentration and the liver total cholesterol concentration.
It was also confirmed that theaflavin has the effect of reducing serum total cholesterol concentration and liver total cholesterol concentration.
Since these active ingredients are ingredients contained in the mixed fermented tea leaves, they are highly safe.

Claims (1)

数平均分子量が5,970かつ重量平均分子量が13,200であるカテキン酸化重合体からなるコレステロール低減剤。 A cholesterol reducing agent comprising a catechin oxidized polymer having a number average molecular weight of 5,970 and a weight average molecular weight of 13,200.
JP2009035709A 2009-02-18 2009-02-18 Cholesterol reducing agent Active JP5232979B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009035709A JP5232979B2 (en) 2009-02-18 2009-02-18 Cholesterol reducing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009035709A JP5232979B2 (en) 2009-02-18 2009-02-18 Cholesterol reducing agent

Publications (2)

Publication Number Publication Date
JP2010189321A JP2010189321A (en) 2010-09-02
JP5232979B2 true JP5232979B2 (en) 2013-07-10

Family

ID=42815773

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009035709A Active JP5232979B2 (en) 2009-02-18 2009-02-18 Cholesterol reducing agent

Country Status (1)

Country Link
JP (1) JP5232979B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102212667B1 (en) * 2018-03-19 2021-02-05 스푸라우트 코포레이션 리미티드 Extract of plant, preparation method and use thereof, and cosmeceutical and product comprising extract of plant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006013866A1 (en) * 2004-08-03 2006-02-09 Nagasaki Prefectural Government Fermented tea produced by rubbing starting tea leaves and japanese medlar leaves and composition having extract contained in the fermented tea as the active ingredient
JP4701328B2 (en) * 2006-02-02 2011-06-15 長崎県 Fermented tea leaves and production method thereof, fermented tea leaf extract and food and drink

Also Published As

Publication number Publication date
JP2010189321A (en) 2010-09-02

Similar Documents

Publication Publication Date Title
Vuong et al. Extraction and isolation of catechins from tea
Hirunpanich et al. Hypocholesterolemic and antioxidant effects of aqueous extracts from the dried calyx of Hibiscus sabdariffa L. in hypercholesterolemic rats
JP5324084B2 (en) Cowberry extract and its production method and use
Kawakami et al. Major water-soluble polyphenols, proanthocyanidins, in leaves of persimmon (Diospyros kaki) and their α-amylase inhibitory activity
Mao et al. Polysaccharides from Chinese Liupao dark tea and their protective effect against hyperlipidemia
JPH0222755B2 (en)
JP4701328B2 (en) Fermented tea leaves and production method thereof, fermented tea leaf extract and food and drink
CN101454015A (en) Extracts and methods comprising green tea species
JPH10506903A (en) Methods of making and using antineoplastic cocoa extracts
JP2009013159A6 (en) Cowberry extract and its production method and use
EP0810222B1 (en) Process for extraction of polyphenolic compounds of catechin type from plants, the so obtained extract and its use
WO2001056586A1 (en) Method for the isolation of caffeine-free catechins from green tea
JP2007231009A (en) Composition for inhibiting blood glucose level elevation and food or drink containing the same
KR100486763B1 (en) Extracts of Phyllostachys edulis leaf having antioxidant activity and the process for preparation thereof
CN105983016B (en) A pharmaceutical composition containing silybin
JP4822291B2 (en) Liver fibrosis inhibitor
CN110724121B (en) Bibenzyl derivative in dendrobium officinale leaf and preparation method and application thereof
JP5232979B2 (en) Cholesterol reducing agent
JP2009221158A (en) Neutral fat-reducing agent and suppressor of body fat increase
JP4922551B2 (en) Maple syrup fortified with bioactive phenolic compounds
KR102464052B1 (en) Composition of complex-fermented sprout ginseng having increased ginsenoside F2, Rg3, Rd2 and compound K, chlorogenic acid, coumaric acid, catechin and quercetin, and preparation method thereof
JP2012005413A (en) Method for preparing fermented tea extract containing polymer polyphenol
JP3967564B2 (en) Lemon fermented product and method for producing the same
JP2005001998A (en) Hypotensive agent, method for producing the same and propolis composition and food formulation
WO2013081046A1 (en) Extract derived from grape rachis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120807

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121004

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121214

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130115

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130214

R150 Certificate of patent or registration of utility model

Ref document number: 5232979

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160405

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250